Hosted on MSN

Sino Biopharmaceutical Advances Respiratory Drug Portfolio with Promising Study Results

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Sino Biopharmaceutical ( (HK:1177)) just ...
Nasdaq

Partex NV and Fortress Biotech, Inc. Announce Strategic Collaboration to Leverage AI in Biopharmaceutical Drug Discovery

The collaboration with Partex enables Fortress to utilize advanced AI-driven technology for efficient identification and evaluation of biopharmaceutical assets, potentially leading to innovative ...
Morningstar

Inductive Bio Announces an Up To $21M Award to Develop AI Drug Toxicity Models that Improve Drug Safety Assessment with Leading Academic and Biopharmaceutical Organizations

Team to develop and validate computational models trained on data from organoids and advanced human model systems that will improve drug safety and reduce reliance on animal testing NEW YORK, Dec. 8, ...